Fulcrum Therapeutics Company

Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
Technology: Cancer
Industry: Loss of Proteostasis
Headquarters: United States
Founded Date: 2016
Employees Number: 51-100
Funding Status: IPO
Estimated Revenue: $1B to $10B

Visit Website
Register and Claim Ownership